drugset / Trial / NCT03296787
A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the effect of varying degrees of renal function on the PK of TAK-954 following single-dose IV administration and to investigate the impact of hemodialysis on the PK of single IV doses of TAK-954.
Timeline
- Start
- 2017-11-21
- Primary completion
- 2019-08-09
- Completion
- 2019-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | felcisetrag | Small molecule | 0.2 mg | Intravenous |